SOM Biotech

SOM Biotech is a clinical-stage drug discovery and development company focused on repurposing drugs for orphan diseases. Its drug discovery is based on a proprietary artificial intelligence repurposing. The Company's portfolio of products includes drugs for rare diseases such as huntington, adrenoleukodystrophy, adrenomyeloneuropathy, and phenylketonuria as well other drugs for different therapeutic areas.